跳至主要内容
临床试验/NCT04572581
NCT04572581已完成不适用

Use of Human Milk-Based Diet in the Late Preterm and Term Infant in the Neonatal Intensive Care Unit: A Pilot Randomized Controlled Trial

University of California, Los Angeles4 个研究点 分布在 1 个国家目标入组 32 人开始时间: 2020年11月1日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
32
试验地点
4
主要终点
Study Feasibility_1

研究概览

简要总结

The purpose of this pilot study is to determine if a randomized controlled study comparing a human milk diet versus a formula supplemented diet in late preterm and term infants in the neonatal intensive care unit (NICU) is feasible.

详细描述

In late preterm infants and term neonates in the NICU whose mothers intend to breastfeed, this pilot study seeks to 1. determine study feasibility (consent rate, study completion rate, and rate of adherence to study diet), and 2. determine whether a dietary supplementation with donor human milk vs. formula improves: a. the percentage of maternal milk consumption at time of discharge from the NICU, or 7 days of age, whichever is later, b. breastfeeding rates and intent to breastfeed at 6-8 weeks chronological age, and c. breast feeding duration.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Other
盲法
None

入排标准

年龄范围
— 至 3 Days(Child)
性别
All
接受健康志愿者

入选标准

  • Gestational age >34 weeks and 0 days
  • Mother's intent to breast feed
  • NICU admission which is predicted to be at least 72 hours from time of admission

排除标准

  • Confirmed genetic disorders and syndromes or other disorders known to affect growth and ability to bottle feed or breast feed (i.e., Trisomies)
  • Common neonatal congenital anomalies (cardiac disease, congenital gastrointestinal disorders, etc)
  • Commonly accepted contraindications for breast feeding (HIV, galactosemia, herpes lesions on the breast, maternal use of drugs that are considered contraindicated with breast feeding including marijuana)
  • Infant admitted to the intensive care unit who is receiving invasive respiratory support (intubation) and/or ionotropic medications
  • Any infant whose care is considered futile by the primary medical team

结局指标

主要结局

Study Feasibility_1

时间窗: 6-8 weeks chronological age

Feasibility will be evaluated by: consent rate

Study Feasibility_2

时间窗: 6-8 weeks chronological age

Feasibility will be evaluated by: study completion rate

Study Feasibility_3

时间窗: 6-8 weeks chronological age

Feasibility will be evaluated by: rate of adherence to the study diet.

次要结局

  • Growth: Height(6-8 weeks chronological age)
  • Percentage of Human Milk Consumption at Discharge(at the time of NICU discharge or 7 days of age, whichever is later)
  • Percentage of Human Milk Consumption After Discharge(6-8 weeks chronological age)
  • Growth: Head Circumference(6-8 weeks chronological age)
  • Breastfeeding duration(6-8 weeks chronological age)
  • Growth: Weight(6-8 weeks chronological age)
  • Intent to Breastfeed(6-8 weeks chronological age)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Kara L. Calkins, MD

Health Sciences Clinical Assistant Professor, Pediatric Neonatology

University of California, Los Angeles

研究点 (4)

Loading locations...

相似试验

Donor Breast Milk and Breastfeeding Rates | 临床试验